American Society of Hirudotherapy

Sciatica (Non-Discogenic / Piriformis)

Investigational use for non-discogenic sciatica including piriformis syndrome; no controlled trial, only an old unquantified Russian case series.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 12, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for sciatica. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for non-discogenic sciatica is investigational.
What evidence exists?
Tier C (investigational). No study of leech therapy in piriformis syndrome was identified; the only series found is an old, unquantified Russian series of 50 patients with sciatic-nerve neuritis or neuralgia that reported positive results. There are no randomized controlled trials for non-discogenic sciatica. Discogenic sciatica has a separate entry (lumbar-radiculopathy). Standard care — physical therapy, NSAIDs, neuropathic-pain medications, image-guided injections, and surgical evaluation for red flags — remains first-line.
Main risks
  • Bleeding from each bite site for 6 to 24 hours after detachment
  • Bruising and tenderness over the lower back, buttock, and posterior thigh for 5 to 10 days
  • Itching and irritation at bite sites for days to weeks
  • Local skin infection or, rarely, Aeromonas infection
  • Allergic reaction to leech saliva (uncommon)
  • Temporary worsening of pain for 1 to 2 days after the session
  • Small bite marks that usually fade over weeks to months (rarely a pale spot stays longer)
Who should not consider this
  • Patients on blood thinners (anticoagulants such as warfarin, DOACs or heparin)
  • Patients with hemophilia or other bleeding disorders
  • Patients with anemia
  • Patients with cauda equina syndrome — loss of bladder or bowel control, saddle numbness (surgical emergency, go to ER)
  • Patients with progressive leg weakness or foot drop (urgent surgical evaluation)
  • Patients with any sign of spinal infection (fever, IV drug use, recent spinal procedure)
  • Patients with malignancy and new back pain (rule out metastasis first)
What to ask your clinician
  • Have I had imaging (MRI) and a workup ruling out red-flag features?
  • Is my sciatica truly non-discogenic, or do I need a spine-surgery evaluation?
  • Have I completed physical therapy, NSAIDs, and neuropathic-pain medications?
  • What evidence supports leech therapy for non-discogenic sciatica specifically?
  • What is the practitioner's experience and Aeromonas-prevention plan?
  • What is the realistic chance of benefit, and for how long?
  • What is the cost, and what does it commit me to?
When to seek urgent care
  • Loss of bladder or bowel control, saddle numbness (cauda equina — go to ER immediately)
  • New or worsening leg weakness or foot drop
  • Severe back pain with fever (possible spinal infection)
  • Bleeding from bite sites lasting more than 24 to 48 hours
  • Spreading redness, warmth, pus, or red streaks (cellulitis)
  • Fever above 38.0 C / 100.4 F or chills
  • Hives, throat tightness, or breathing difficulty

What this does NOT mean

  • This is not FDA-cleared for sciatica.
  • Mechanism rationale (local anti-inflammation) does NOT establish clinical efficacy.
  • Small uncontrolled case series are not evidence of efficacy in the general sciatica population.
  • Leech therapy is not a substitute for spine-surgery evaluation when red flags are present.
  • Reported symptom improvement does not predict durable benefit or address underlying anatomy.

Clinical Profile

Category
Neurological
ICD-10
M54.30, M54.31, M54.32, G57.00
Safety tier
Low

Evidence Summary

Non-discogenic sciatica — including piriformis syndrome and proximal sciatic neuralgia — is a less reproducible diagnostic category than disc-related lumbar radiculopathy, and no controlled trial or quantified case series of leech therapy specific to it was identified in PubMed, Europe PMC, ClinicalTrials.gov or Russian-language sources. The only series found is an old, unquantified one: Kasimov described 50 patients with neuritis or neuralgia of the sciatic nerve and reported positive results, as summarized in the Baskova and Isakhanyan monograph (2004). No study of leech therapy for piriformis syndrome was identified, and no reliable effect size is established. The closest genuine evidence is for a distinct condition, chronic low back pain, rather than sciatica, so it cannot be transferred to this indication. Imaging (MRI of the lumbar spine and pelvis) should rule out treatable structural causes before leech therapy is considered, and its use here remains investigational.

What the books describe

Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.

  • Directly on pain along the sciatic nerve, Baskova and Isakhanyan retell Kasimov’s method from the 1990 methodological recommendations: 50 patients with neuritis or neuralgia of the sciatic nerve; according to this retelling, treatment with leeches considerably shortened the time to recovery and gave positive results[B1].
  • What the treatment was compared with, how the result was assessed and how long the patients were followed is not described in the retelling, and the cause of the pain (a disc herniation or another) is not named[B1].
  • In the same chapter, vertebrogenic radiculopathies are also listed among the indications (disc herniations and bulges are named as the most common cause of pain), and reports on 37 and 280 patients are given, but the sciatic nerve is not mentioned separately in them[B1].
  • Michalsen et al. write that for lumboischialgia and chronic pain due to lumbar disc herniation, hirudotherapy can be a useful adjunct to physical therapy and pain management[B3].
  • Neither Baskova and Isakhanyan nor Michalsen et al. discuss which manifestations of leg pain coming from the lower back require emergency care, so this question cannot be settled from these books; Michalsen et al. only write that for pain in the lower back (lumbago), a disc herniation and other primary causes must be excluded before treatment starts[B3].
  • Both books list hemophilia, anemia and concurrent use of anticoagulants among the contraindications (this is only part of their lists); Flecken and Michalsen add that aspirin or clopidogrel are not in themselves considered a contraindication, but in that case the number of leeches is reduced at the first session[B1][B3].

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Key Trials

  1. Hohmann CD et al. (2018), n=44 · Dtsch Arztebl Int · PMID 30636672 · ASH analysis →

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Progressive motor deficit (surgical evaluation)
  • Untreated lumbar disc herniation with structural indication

Related Conditions

References

  • [B1]

    Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]

    Москва: Монолит(2004)https://search.rsl.ru/ru/record/01007959553

    Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.

  • [B3]

    Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy

    Stuttgart — New York: Thieme(2007)https://books.google.com/books?vid=ISBN9781588905635

    ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.

The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.